LGND logo

LGND Depreciation and amortization

annual D&A:

$37.37M-$13.00K(-0.03%)
December 31, 2024

Summary

  • As of today (September 14, 2025), LGND annual depreciation & amortization is $37.37 million, with the most recent change of -$13.00 thousand (-0.03%) on December 31, 2024.
  • During the last 3 years, LGND annual D&A has fallen by -$18.42 million (-33.02%).
  • LGND annual D&A is now -34.32% below its all-time high of $56.89 million, reached on December 31, 2022.

Performance

1-year change

-0.03%

3-year change

-33.02%

5-year change

-14.56%

15-year change

+218.98%

LGND Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

83.04%
LGND annual depreciation & amortization is higher than 83.04% of companies in Healthcare sector

Range

All-time high

$56.89M
LGND annual depreciation & amortization is currently -34.32% below its historical high of $56.89 million

3-year low

$37.37M
LGND annual depreciation & amortization is currently at its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
LGND previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
LGND next annual earnings announcement has not yet been scheduled

OtherLGNDincome statement metrics

Annual total expenses

$171.16M
LGND annual total expenses is $171.16 million

annual operating expenses

$97.78M
LGND annual total operating expenses is $97.78 million

annual cost of goods sold

$46.33M
LGND annual cost of goods sold is $46.33 million

annual interest expense

$0.00
LGND annual interest expense is $0.00

quarterly D&A:

$8.93M-$407.00K(-4.36%)
June 30, 2025

Summary

  • As of today (September 14, 2025), LGND quarterly depreciation & amortization is $8.93 million, with the most recent change of -$407.00 thousand (-4.36%) on June 30, 2025.
  • Over the past year, LGND quarterly D&A has dropped by -$423.00 thousand (-4.52%).
  • LGND quarterly D&A is now -71.34% below its all-time high of $31.17 million, reached on December 31, 2019.

Performance

3-month change

-4.36%

1-year change

-4.52%

3-year change

-39.02%

5-year change

+111.61%

LGND quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

82.04%
LGND quarterly depreciation & amortization is higher than 82.04% of companies in Healthcare sector

Range

All-time high

$31.17M
LGND quarterly depreciation & amortization is currently -71.34% below its historical high of $31.17 million

3-year low

$8.88M
LGND quarterly depreciation & amortization is currently +0.65% above its 3-year low

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
LGND previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Nov 6, 2025
LGND next earnings announcement is scheduled for Nov 6, 2025

OtherLGNDincome statement metrics

Quarterly total expenses

$42.78M
LGND quarterly total expenses is $42.78 million

quarterly operating expenses

$26.74M
LGND quarterly total operating expenses is $26.74 million

quarterly cost of goods sold

$11.16M
LGND quarterly cost of goods sold is $11.16 million

quarterly interest expense

$0.00
LGND quarterly interest expense is $0.00

TTM D&A:

$37.04M-$423.00K(-1.13%)
June 30, 2025

Summary

  • As of today (September 14, 2025), LGND TTM depreciation & amortization is $37.04 million, with the most recent change of -$423.00 thousand (-1.13%) on June 30, 2025.
  • Over the past year, LGND TTM D&A has increased by +$139.00 thousand (+0.38%).
  • LGND TTM D&A is now -40.79% below its all-time high of $62.56 million, reached on September 30, 2022.

Performance

3-month change

-1.13%

1-year change

+0.38%

3-year change

-38.46%

5-year change

-18.69%

LGND TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

81.85%
LGND TTM depreciation & amortization is higher than 81.85% of companies in Healthcare sector

Range

All-time high

$62.56M
LGND TTM depreciation & amortization is currently -40.79% below its historical high of $62.56 million

3-year low

$36.90M
LGND TTM depreciation & amortization is currently +0.38% above its 3-year low

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
LGND previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Nov 6, 2025
LGND next earnings announcement is scheduled for Nov 6, 2025

OtherLGNDincome statement metrics

Annual total expenses

$171.16M
LGND annual total expenses is $171.16 million

annual operating expenses

$97.78M
LGND annual total operating expenses is $97.78 million

TTM cost of goods sold

$46.07M
LGND TTM cost of goods sold is $46.07 million

TTM interest expense

$0.00
LGND TTM interest expense is $0.00

LGND Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-0.0%-4.5%+0.4%
3 y3 years-33.0%-39.0%-38.5%
5 y5 years-14.6%+111.6%-18.7%

LGND Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-34.3%at low-40.4%+0.7%-40.8%+0.4%
5 y5-year-34.3%+33.6%-49.8%+111.6%-40.8%+32.5%
alltimeall time-34.3%+4289.7%-71.3%+1077.5%-40.8%+9160.0%

LGND Depreciation and amortization History

DateAnnualQuarterlyTTM
Jun 2025
-
$8.93M(-4.4%)
$37.04M(-1.1%)
Mar 2025
-
$9.34M(+1.6%)
$37.46M(+0.3%)
Dec 2024
$37.37M(-0.0%)
$9.20M(-3.9%)
$37.37M(-0.6%)
Sep 2024
-
$9.57M(+2.2%)
$37.59M(+1.9%)
Jun 2024
-
$9.36M(+1.2%)
$36.90M(-0.4%)
Mar 2024
-
$9.24M(-1.9%)
$37.05M(-0.9%)
Dec 2023
$37.38M(-34.3%)
$9.43M(+6.2%)
$37.38M(-6.7%)
Sep 2023
-
$8.88M(-6.7%)
$40.07M(-13.2%)
Jun 2023
-
$9.51M(-0.6%)
$46.18M(-10.0%)
Mar 2023
-
$9.57M(-21.1%)
$51.32M(-9.8%)
Dec 2022
$56.89M(+2.0%)
$12.12M(-19.1%)
$56.89M(-9.1%)
Sep 2022
-
$14.99M(+2.3%)
$62.56M(+3.9%)
Jun 2022
-
$14.65M(-3.2%)
$60.19M(+4.1%)
Mar 2022
-
$15.13M(-14.9%)
$57.83M(+3.7%)
Dec 2021
$55.79M(+99.5%)
$17.79M(+41.0%)
$55.79M(+9.8%)
Sep 2021
-
$12.61M(+2.6%)
$50.81M(+18.9%)
Jun 2021
-
$12.29M(-6.1%)
$42.75M(+23.3%)
Mar 2021
-
$13.09M(+2.2%)
$34.68M(+24.0%)
Dec 2020
$27.97M(-36.0%)
$12.82M(+181.8%)
$27.97M(-39.6%)
Sep 2020
-
$4.55M(+7.7%)
$46.32M(+1.7%)
Jun 2020
-
$4.22M(-33.8%)
$45.55M(+1.2%)
Mar 2020
-
$6.38M(-79.5%)
$45.02M(+3.0%)
Dec 2019
$43.73M(+197.1%)
$31.17M(+724.8%)
$43.73M(+175.8%)
Sep 2019
-
$3.78M(+2.3%)
$15.86M(-9.3%)
Jun 2019
-
$3.69M(-27.3%)
$17.49M(+4.1%)
Mar 2019
-
$5.09M(+54.3%)
$16.80M(+14.2%)
Dec 2018
$14.72M(+25.6%)
$3.30M(-39.0%)
$14.72M(-5.4%)
Sep 2018
-
$5.41M(+79.6%)
$15.55M(+27.9%)
Jun 2018
-
$3.01M(+0.3%)
$12.16M(+3.6%)
Mar 2018
-
$3.00M(-27.4%)
$11.74M(+0.2%)
Dec 2017
$11.71M(+3.8%)
$4.13M(+104.9%)
$11.71M(+11.0%)
Sep 2017
-
$2.02M(-22.0%)
$10.55M(-8.0%)
Jun 2017
-
$2.58M(-13.2%)
$11.47M(-1.9%)
Mar 2017
-
$2.98M(+0.4%)
$11.69M(+3.6%)
Dec 2016
$11.29M(+329.8%)
$2.97M(+1.2%)
$11.29M(+25.3%)
Sep 2016
-
$2.93M(+4.3%)
$9.01M(+34.1%)
Jun 2016
-
$2.81M(+9.2%)
$6.72M(+47.6%)
Mar 2016
-
$2.58M(+274.8%)
$4.55M(+73.3%)
Dec 2015
$2.63M(-1.1%)
$687.00K(+6.7%)
$2.63M(+1.1%)
Sep 2015
-
$644.00K(-0.3%)
$2.60M(-0.6%)
Jun 2015
-
$646.00K(-0.6%)
$2.62M(-0.9%)
Mar 2015
-
$650.00K(-1.4%)
$2.64M(-0.7%)
Dec 2014
$2.66M(-0.2%)
$659.00K(-0.3%)
$2.66M(+0.1%)
Sep 2014
-
$661.00K(-1.2%)
$2.65M(-0.3%)
Jun 2014
-
$669.00K(+0.1%)
$2.66M(0.0%)
Mar 2014
-
$668.00K(+1.8%)
$2.66M(-0.1%)
Dec 2013
$2.66M(-2.3%)
$656.00K(-1.8%)
$2.66M(-3.4%)
Sep 2013
-
$668.00K(-0.1%)
$2.76M(+1.1%)
Jun 2013
-
$669.00K(-0.1%)
$2.73M(+0.3%)
Mar 2013
-
$670.00K(-10.5%)
$2.72M(-0.3%)
Dec 2012
$2.73M(-2.3%)
$749.00K(+17.4%)
$2.73M(+2.2%)
Sep 2012
-
$638.00K(-3.6%)
$2.67M(-4.0%)
Jun 2012
-
$662.00K(-2.4%)
$2.78M(-4.2%)
Mar 2012
-
$678.00K(-1.9%)
$2.90M(+4.1%)
Dec 2011
$2.79M(+26.1%)
$691.00K(-7.9%)
$2.79M(+27.2%)
Sep 2011
-
$750.00K(-4.5%)
$2.19M(+3.8%)
Jun 2011
-
$785.00K(+39.2%)
$2.11M(+4.0%)
Mar 2011
-
$564.00K(+493.7%)
$2.03M(-8.2%)
Dec 2010
$2.21M(-52.3%)
$95.00K(-85.8%)
$2.21M(-49.5%)
Sep 2010
-
$669.00K(-4.8%)
$4.38M(+5.1%)
Jun 2010
-
$703.00K(-5.6%)
$4.17M(-5.2%)
Mar 2010
-
$745.00K(-67.1%)
$4.40M(-5.1%)
Dec 2009
$4.63M
$2.26M(+395.4%)
$4.63M(+77.7%)
DateAnnualQuarterlyTTM
Sep 2009
-
$457.00K(-51.0%)
$2.61M(+7.9%)
Jun 2009
-
$932.00K(-5.0%)
$2.42M(+39.3%)
Mar 2009
-
$981.00K(+312.2%)
$1.74M(+64.9%)
Dec 2008
$1.05M(-59.8%)
$238.00K(-10.5%)
$1.05M(-10.7%)
Sep 2008
-
$266.00K(+6.4%)
$1.18M(-10.1%)
Jun 2008
-
$250.00K(-16.1%)
$1.31M(-13.1%)
Mar 2008
-
$298.00K(-18.1%)
$1.51M(-42.3%)
Dec 2007
$2.62M(-83.0%)
$364.00K(-8.8%)
$2.62M(-45.6%)
Sep 2007
-
$399.00K(-10.7%)
$4.81M(-42.4%)
Jun 2007
-
$447.00K(-68.2%)
$8.35M(-32.2%)
Mar 2007
-
$1.41M(-45.1%)
$12.30M(-20.0%)
Dec 2006
$15.38M(-12.9%)
$2.56M(-35.1%)
$15.38M(-7.1%)
Sep 2006
-
$3.94M(-10.6%)
$16.56M(-4.7%)
Jun 2006
-
$4.40M(-1.8%)
$17.37M(-1.8%)
Mar 2006
-
$4.48M(+19.9%)
$17.69M(+0.1%)
Dec 2005
$17.67M(+23.6%)
$3.74M(-21.2%)
$17.67M(+4.5%)
Sep 2005
-
$4.75M(+0.5%)
$16.90M(+5.5%)
Jun 2005
-
$4.72M(+5.9%)
$16.02M(+7.2%)
Mar 2005
-
$4.46M(+50.1%)
$14.95M(+4.5%)
Dec 2004
$14.30M(+6.6%)
$2.97M(-23.2%)
$14.30M(-2.6%)
Sep 2004
-
$3.87M(+6.0%)
$14.68M(+4.0%)
Jun 2004
-
$3.65M(-4.2%)
$14.11M(+2.3%)
Mar 2004
-
$3.81M(+13.8%)
$13.79M(+2.8%)
Dec 2003
$13.41M(+28.1%)
$3.35M(+1.4%)
$13.41M(-25.9%)
Sep 2003
-
$3.30M(-0.8%)
$18.11M(+30.4%)
Jun 2003
-
$3.33M(-3.0%)
$13.89M(+13.1%)
Mar 2003
-
$3.43M(-57.3%)
$12.28M(+17.3%)
Dec 2002
$10.47M(+59.3%)
$8.04M(-980.0%)
$10.47M(+178.5%)
Sep 2002
-
-$914.00K(-153.2%)
$3.76M(-41.1%)
Jun 2002
-
$1.72M(+5.8%)
$6.38M(-1.8%)
Mar 2002
-
$1.62M(+22.0%)
$6.50M(-1.1%)
Dec 2001
$6.57M(-5.7%)
$1.33M(-22.2%)
$6.57M(-4.2%)
Sep 2001
-
$1.71M(-6.8%)
$6.86M(-1.1%)
Jun 2001
-
$1.83M(+8.1%)
$6.94M(+1.9%)
Mar 2001
-
$1.70M(+4.7%)
$6.81M(-2.3%)
Dec 2000
$6.97M(+0.9%)
$1.62M(-9.2%)
$6.97M(-2.4%)
Sep 2000
-
$1.78M(+4.5%)
$7.15M(+2.8%)
Jun 2000
-
$1.71M(-8.1%)
$6.95M(-2.4%)
Mar 2000
-
$1.86M(+3.5%)
$7.12M(+3.1%)
Dec 1999
$6.91M(+59.7%)
$1.80M(+12.9%)
$6.91M(+11.0%)
Sep 1999
-
$1.59M(-15.2%)
$6.22M(+9.3%)
Jun 1999
-
$1.88M(+14.0%)
$5.69M(+15.8%)
Mar 1999
-
$1.65M(+48.1%)
$4.92M(+13.7%)
Dec 1998
$4.33M(+4.7%)
$1.11M(+4.7%)
$4.33M(-26.9%)
Sep 1998
-
$1.06M(-3.6%)
$5.92M(-19.6%)
Jun 1998
-
$1.10M(+4.6%)
$7.35M(-14.0%)
Mar 1998
-
$1.05M(-61.0%)
$8.55M(-12.7%)
Dec 1997
$4.13M(+6.5%)
$2.70M(+8.0%)
$9.80M(+2.1%)
Sep 1997
-
$2.50M(+8.7%)
$9.60M(-17.9%)
Jun 1997
-
$2.30M(0.0%)
$11.70M(+10.4%)
Mar 1997
-
$2.30M(-8.0%)
$10.60M(+12.8%)
Dec 1996
$3.88M(+44.3%)
$2.50M(-45.7%)
$9.40M(+36.2%)
Sep 1996
-
$4.60M(+283.3%)
$6.90M(+200.0%)
Jun 1996
-
$1.20M(+9.1%)
$2.30M(+109.1%)
Mar 1996
-
$1.10M(+57.1%)
$1.10M(-60.7%)
Dec 1995
$2.69M(+74.9%)
-
-
Mar 1995
-
$700.00K(-50.0%)
$2.80M(+12.0%)
Dec 1994
$1.54M(+21.0%)
$1.40M(+250.0%)
$2.50M(+127.3%)
Sep 1994
-
$400.00K(+33.3%)
$1.10M(+57.1%)
Jun 1994
-
$300.00K(-25.0%)
$700.00K(+75.0%)
Mar 1994
-
$400.00K
$400.00K
Dec 1993
$1.27M(+49.1%)
-
-
Dec 1992
$851.20K
-
-

FAQ

  • What is Ligand Pharmaceuticals Incorporated annual depreciation & amortization?
  • What is the all time high annual D&A for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated annual D&A year-on-year change?
  • What is Ligand Pharmaceuticals Incorporated quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated quarterly D&A year-on-year change?
  • What is Ligand Pharmaceuticals Incorporated TTM depreciation & amortization?
  • What is the all time high TTM D&A for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated TTM D&A year-on-year change?

What is Ligand Pharmaceuticals Incorporated annual depreciation & amortization?

The current annual D&A of LGND is $37.37M

What is the all time high annual D&A for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high annual depreciation & amortization is $56.89M

What is Ligand Pharmaceuticals Incorporated annual D&A year-on-year change?

Over the past year, LGND annual depreciation & amortization has changed by -$13.00K (-0.03%)

What is Ligand Pharmaceuticals Incorporated quarterly depreciation & amortization?

The current quarterly D&A of LGND is $8.93M

What is the all time high quarterly D&A for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high quarterly depreciation & amortization is $31.17M

What is Ligand Pharmaceuticals Incorporated quarterly D&A year-on-year change?

Over the past year, LGND quarterly depreciation & amortization has changed by -$423.00K (-4.52%)

What is Ligand Pharmaceuticals Incorporated TTM depreciation & amortization?

The current TTM D&A of LGND is $37.04M

What is the all time high TTM D&A for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high TTM depreciation & amortization is $62.56M

What is Ligand Pharmaceuticals Incorporated TTM D&A year-on-year change?

Over the past year, LGND TTM depreciation & amortization has changed by +$139.00K (+0.38%)
On this page